396 related articles for article (PubMed ID: 34609505)
1. Atherosclerosis is a major human killer and non-resolving inflammation is a prime suspect.
Fredman G; MacNamara KC
Cardiovasc Res; 2021 Nov; 117(13):2563-2574. PubMed ID: 34609505
[TBL] [Abstract][Full Text] [Related]
2. Inflammation and atherosclerosis: what is on the horizon?
Ruparelia N; Choudhury R
Heart; 2020 Jan; 106(1):80-85. PubMed ID: 31843811
[No Abstract] [Full Text] [Related]
3. Atherosclerosis and autoimmunity: a growing relationship.
Sanjadi M; Rezvanie Sichanie Z; Totonchi H; Karami J; Rezaei R; Aslani S
Int J Rheum Dis; 2018 May; 21(5):908-921. PubMed ID: 29671956
[TBL] [Abstract][Full Text] [Related]
4. The role of non-resolving inflammation in atherosclerosis.
Kasikara C; Doran AC; Cai B; Tabas I
J Clin Invest; 2018 Jul; 128(7):2713-2723. PubMed ID: 30108191
[TBL] [Abstract][Full Text] [Related]
5. Macrophages and dendritic cells: the usual suspects in atherogenesis.
Kassiteridi C; Monaco C
Curr Drug Targets; 2015; 16(4):373-82. PubMed ID: 25808566
[TBL] [Abstract][Full Text] [Related]
6. Exploring immune checkpoints as potential therapeutic targets in atherosclerosis.
Kusters PJH; Lutgens E; Seijkens TTP
Cardiovasc Res; 2018 Mar; 114(3):368-377. PubMed ID: 29309533
[TBL] [Abstract][Full Text] [Related]
7. Functional diversity of macrophages in vascular biology and disease.
Park I; Kassiteridi C; Monaco C
Vascul Pharmacol; 2017 Dec; 99():13-22. PubMed ID: 29074468
[TBL] [Abstract][Full Text] [Related]
8. Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions.
Raggi P; Genest J; Giles JT; Rayner KJ; Dwivedi G; Beanlands RS; Gupta M
Atherosclerosis; 2018 Sep; 276():98-108. PubMed ID: 30055326
[TBL] [Abstract][Full Text] [Related]
9. Novel anti-inflammatory therapies for the treatment of atherosclerosis.
Khan R; Spagnoli V; Tardif JC; L'Allier PL
Atherosclerosis; 2015 Jun; 240(2):497-509. PubMed ID: 25917947
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in therapeutic targeting of inflammation in atherosclerosis.
Hedin U; Matic LP
J Vasc Surg; 2019 Mar; 69(3):944-951. PubMed ID: 30591299
[TBL] [Abstract][Full Text] [Related]
11. Immunometabolism and atherosclerosis: perspectives and clinical significance: a position paper from the Working Group on Atherosclerosis and Vascular Biology of the European Society of Cardiology.
Ketelhuth DFJ; Lutgens E; Bäck M; Binder CJ; Van den Bossche J; Daniel C; Dumitriu IE; Hoefer I; Libby P; O'Neill L; Weber C; Evans PC
Cardiovasc Res; 2019 Jul; 115(9):1385-1392. PubMed ID: 31228191
[TBL] [Abstract][Full Text] [Related]
12. Specialized pro-resolving mediators in vascular inflammation and atherosclerotic cardiovascular disease.
Fredman G; Serhan CN
Nat Rev Cardiol; 2024 Jan; ():. PubMed ID: 38216693
[TBL] [Abstract][Full Text] [Related]
13. 2016 Russell Ross Memorial Lecture in Vascular Biology: Molecular-Cellular Mechanisms in the Progression of Atherosclerosis.
Tabas I
Arterioscler Thromb Vasc Biol; 2017 Feb; 37(2):183-189. PubMed ID: 27979856
[TBL] [Abstract][Full Text] [Related]
14. Fine-tuning inflammation-resolution programs: focus on atherosclerosis.
Fredman G; Sadhu S; Rymut N
Curr Opin Clin Nutr Metab Care; 2017 Mar; 20(2):117-123. PubMed ID: 27984234
[TBL] [Abstract][Full Text] [Related]
15. Inflammation during the life cycle of the atherosclerotic plaque.
Libby P
Cardiovasc Res; 2021 Nov; 117(13):2525-2536. PubMed ID: 34550337
[TBL] [Abstract][Full Text] [Related]
16. Targeting the immune response in atherosclerosis: It's time for clinical trials!
Joffre J; Ait-Oufella H
Arch Cardiovasc Dis; 2017 Dec; 110(12):643-645. PubMed ID: 29051009
[No Abstract] [Full Text] [Related]
17. Atherosclerosis and immunity: A perspective.
Abdolmaleki F; Gheibi Hayat SM; Bianconi V; Johnston TP; Sahebkar A
Trends Cardiovasc Med; 2019 Aug; 29(6):363-371. PubMed ID: 30292470
[TBL] [Abstract][Full Text] [Related]
18. The role of damage- and pathogen-associated molecular patterns in inflammation-mediated vulnerability of atherosclerotic plaques.
Rai V; Agrawal DK
Can J Physiol Pharmacol; 2017 Oct; 95(10):1245-1253. PubMed ID: 28746820
[TBL] [Abstract][Full Text] [Related]
19. Polydatin for treating atherosclerotic diseases: A functional and mechanistic overview.
Wu M; Li X; Wang S; Yang S; Zhao R; Xing Y; Liu L
Biomed Pharmacother; 2020 Aug; 128():110308. PubMed ID: 32480216
[TBL] [Abstract][Full Text] [Related]
20. The Utility of Anti-Inflammatory Agents in Cardiovascular Disease: A Novel Perspective on the Treatment of Atherosclerosis.
Kottoor SJ; Arora RR
J Cardiovasc Pharmacol Ther; 2018 Nov; 23(6):483-493. PubMed ID: 29783850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
